These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31917472)

  • 1. Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps.
    Printz C
    Cancer; 2020 Jan; 126(2):239-240. PubMed ID: 31917472
    [No Abstract]   [Full Text] [Related]  

  • 2. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice.
    Beer PA; Cooke SL; Chang DK; Biankin AV
    Ann Oncol; 2019 Nov; 30(11):1691-1694. PubMed ID: 31665210
    [No Abstract]   [Full Text] [Related]  

  • 4. The Changing Face of Oncology Research, Drug Development, and Clinical Practice: Toward Patient-Focused Precision Therapeutics.
    Venkatakrishnan K; van der Graaf PH; Holstein SA
    Clin Pharmacol Ther; 2020 Sep; 108(3):399-404. PubMed ID: 33439492
    [No Abstract]   [Full Text] [Related]  

  • 5. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing cancer drug development through precision medicine and innovative designs.
    Zhang W; Wang J; Menon S
    J Biopharm Stat; 2018; 28(2):229-244. PubMed ID: 29173004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giving Up on Precision Oncology? Not So Fast!
    Warner JL
    Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
    [No Abstract]   [Full Text] [Related]  

  • 8. Ushering in the next generation of precision trials for pediatric cancer.
    DuBois SG; Corson LB; Stegmaier K; Janeway KA
    Science; 2019 Mar; 363(6432):1175-1181. PubMed ID: 30872517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric oncology enters an era of precision medicine.
    Seibel NL; Janeway K; Allen CE; Chi SN; Cho YJ; Glade Bender JL; Kim A; Laetsch TW; Irwin MS; Takebe N; Tricoli JV; Parsons DW
    Curr Probl Cancer; 2017; 41(3):194-200. PubMed ID: 28343740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.
    Smith SM; Wachter K; Burris HA; Schilsky RL; George DJ; Peterson DE; Johnson ML; Markham MJ; Mileham KF; Beg MS; Bendell JC; Dreicer R; Keedy VL; Kimple RJ; Knoll MA; LoConte N; MacKay H; Meisel JL; Moynihan TJ; Mulrooney DA; Mulvey TM; Odenike O; Pennell NA; Reeder-Hayes K; Smith C; Sullivan RJ; Uzzo R
    J Clin Oncol; 2021 Apr; 39(10):1165-1184. PubMed ID: 33527845
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimizing Tomorrow's Drug Development with Project Optimus: Precision Dosing IS Precision Oncology.
    Subbiah V
    Ann Oncol; 2024 Oct; 35(10):836-839. PubMed ID: 39233313
    [No Abstract]   [Full Text] [Related]  

  • 12. Definitions and statistical properties of master protocols for personalized medicine in oncology.
    Renfro LA; Mandrekar SJ
    J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalised medicine in paediatric oncology: Ethical practice outside the clinical trial framework?
    Hansford JR
    J Paediatr Child Health; 2019 Jan; 55(1):10-12. PubMed ID: 30499210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
    Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
    Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
    [No Abstract]   [Full Text] [Related]  

  • 15. Precision Medicine in Pediatric Oncology.
    Vo KT; Parsons DW; Seibel NL
    Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspective on Precision Medicine in Oncology.
    Johnson TM
    Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating anticancer drug development - opportunities and trade-offs.
    Nass SJ; Rothenberg ML; Pentz R; Hricak H; Abernethy A; Anderson K; Gee AW; Harvey RD; Piantadosi S; Bertagnolli MM; Schrag D; Schilsky RL
    Nat Rev Clin Oncol; 2018 Dec; 15(12):777-786. PubMed ID: 30275514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to therapeutic drug development for childhood cancers.
    Campbell K; Ma C; DuBois SG
    Curr Opin Pediatr; 2020 Feb; 32(1):35-40. PubMed ID: 31790026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 20. N-of-1 Trials in Cancer Drug Development.
    Gouda MA; Buschhorn L; Schneeweiss A; Wahida A; Subbiah V
    Cancer Discov; 2023 Jun; 13(6):1301-1309. PubMed ID: 37070849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.